Tags Posts tagged with "Marijuana News"

Marijuana News

0 1154

OTTAWA, ONTARIO–(Marketwired – Jun 14, 2017) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP)(TBP.CN)(CNSX:TBP)(TBPMF) today announced that it has appointed Mr. Carl A. Merton to the Board of Directors, effective immediately.

Mr. Merton has over 20 years of financial and business experience, including 10 years experience as a CFO for public companies involved in the capital markets. Beginning with 12 years combined with Ernst & Young and KPMG, he transitioned from the audit stream into financial advisory work, as a Business Valuator, Forensic Accountant and Corporate Finance functions. After leaving KPMG, Mr. Merton joined Atlas Tube Inc., as Vice-President, Special Projects. After assisting in the sale of Atlas Tube, Mr. Merton became the CFO of Reko International Group Inc. In December 2014, Mr. Merton was elected by shareholders as a member of the inaugural Board of Directors of Aphria Inc. Approximately one year later, Mr. Merton resigned as a member of the Board and joined Aphria as its CFO. In his role as CFO, Mr. Merton is responsible for communication with all stakeholders and is a member of the executive management team responsible for the strategic direction of Aphria, as well as leading all acquisition discussions, budgeting, financing, financial reporting and internal controls. Mr. Merton is a Chartered Professional Accountant, a Chartered Accountant and is a Fellow of the Canadian Institute of Chartered Business Valuators (the “CICBV”). He holds a B.Comm. Hon. in Sports Administration from Laurentian University, and has served as a past Chair of both the CICBV and the International Association of Professional Business Valuators. Mr. Merton is currently a member of the Board of Directors and Chair of the Audit Committee of Motor City Community Credit Union.

“We are most pleased to welcome Mr. Merton to the board as we continue to work closely with our strategic partner, Aphria in building Tetra as a leading bio-pharmaceutical organization,” said Andre Rancourt, Chairman and CEO of Tetra Bio-Pharma. “Mr. Merton’s tremendous experience as a CFO of publicly listed companies has resulted in raising in excess of $200 million. His vast network both in the U.S. and Canada will be a key factor in the Company’s growth. We look forward to working closely with him in building Tetra as a global leader in pharmaceutical cannabis.”

About Tetra Bio-Pharma:
Tetra Bio-Pharma is a multi subsidiary publicly traded company (CSE:TBP)(TBPMF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

Source: Tetra Bio-Pharma

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

0 2162

Proposal Aims For Medical Marijuana Legalization In North Carolina

A recent proposal aims to legalize medical marijuana in North Carolina. The bill lays out the development of a medical marijuana supply system and aims to create a program administered by the UNC system called the North Carolina Cannabis Research Program. The program would conduct studies to determine the safety and efficacy of cannabis as medical treatment and then develop guidelines for the appropriate physician administration and patient use of medical cannabis.

Click Here Now To Read Full Article

Industrial Hemp Project At The University Of Minnesota

University of Minnesota students may do double-takes this summer if they spot what looks like marijuana plants growing on the agricultural testing fields at the St. Paul campus. However, the dark green foliage with jagged leaves will actually be industrial hemp, a close look-alike and cousin to marijuana that’s useless for getting high but potentially valuable for certain foods, cosmetics, and oil.

Click Here Now To Read Full Article

Texas One Step Closer To Decriminalizing Marijuana

Texas is one step closer to eradicating the criminal penalties associated with minor marijuana possession. The House Criminal Jurisprudence Committee recently put its seal of approval on a proposal (House Bill 81) that would allow police all over the state to simply slap those people caught in possession of up to an ounce of weed with a small fine instead of dragging them to jail. The state currently deems this offense a Class B misdemeanor, which carries the potential for marijuana offenders to serve up to six months behind bars.

Click Here Now To Read Full Article

1 6513

HENDERSON, NV–(Marketwired – Oct 24, 2016) – MCIG, Inc., ( OTCQB : MCIG ) a diversified company servicing the legal cannabis, hemp, and CBD markets is pleased to give this corporate update to our current & future shareholders surrounding the operations of MCIG, Inc. First, let me thank the many investor emails I have received over the past few weeks that have made inquiries as to our product lines as well as our Nevada operations, it is for this reason I am providing this update ahead of what we feel is a pivotal moment for the cannabis industry.

The 2016 elections and cannabis related ballots across the United States are exceptionally important to the continued expansion of the industry and we feel MCIG, Inc. is well positioned at many different market verticals, most notable the Nevada cultivation market. Company divisions are fundamentally healthy and we expect to see revenues continues to grow as overall operations expand and are scaled to meet various forms of demand. Currently, 3 of our 4 divisions are profitable as we continue to focus on this profitability via cost cutting initiatives that continue to improve our margins. Also, our cash position has significantly improved while our expenses remain at all-time lows allowing for a good base for future growth.

MCIG continues to expand our shareholders position within the rapidly growing Cannabis market and we have become even more geographically diverse following the addition of new clients, new products roll outs, and continued market penetration via existing product lines and expanded distribution agreements.

In an effort to keep our investors up to date with everything going on within the company, we want to provide this update for each of our portfolio companies and investments as we prepare to enter into the third quarter.

Scalable Solutions -
After being established in March 2016, Scalable Solutions has quickly become a leader when it comes to Marijuana cultivation construction. Currently, we have five projects under construction and a backlog of more than $6 million dollars. Scalable Solutions will become a main driver of revenues for mCig as the legal cannabis industry continues to grow within its Nevada, which is expected to be a $629.5 million market by 2020. The company is also currently working on smaller projects in Washington and Oregon in various capacities while expanding its base of operation in Nevada.

It is important to note that if Nevada legalizes adult use cannabis on November 8, 2016 we will witness an unprecedented socio-economic impact in a state already shaped and fueled by tourism and entertainment. . That’s why we are taking an aggressive approach to contract new projects in Nevada while expanding our professional team of engineers and consultants.

Currently, Scalable’s Sin City and Green Leaf Farms projects under contract are ahead of schedule. Both projects will be expanding as the Nevada markets expand to fulfill their eventual maximum space usage for the large land and warehouse they respectively occupy. Sin City will eventually expand from 4,800 square feet to 40,000 square feet and Green Leaf will modify it entire facility in order to occupy all 30,000 square feet of their facility.

Management expects the Solaris project will become the model for future Green Houses which when completed will be the largest approved green house facility in Nevada with room to grow. The current parcel of Land that Solaris occupies is 12 acres, with only 20% currently allocated by the main Solaris Greenhouse. Many licensed producers are planning on scaling their operations as demand increases as it has increased in other markets. Our scalable division has already seen our current projects swell in size and each of our current clients has expanded the construction budgets multiple times, giving MCIG Inc. via Scalable Solutions years of continued project revenue.

Scalable targets a 10% profit margin on its construction, with monthly management fees and performance incentives. This continued growth along with identifying other avenues for revenues and expansion will ensure Scalable’s long term viability.

VitaCig Brand
The sale of our flagship VITACIG Brand just had a record breaking quarter as VitaCig continues to expand its operations outside of the united states. VitaCig will soon debut in the Philippines, South Africa, and Hungary. With the recent country additions, VitaCig now exports its product to more than 30 different countries.

Part of that success, is due to our R&D department, who continues to develop the world’s most innovative, and unique inhalation technologies and formulas. Within the last few month, VitaCig has released four new concept flavors under the, S-Edition. This Special Line Edition features SURGE B-12 + Energy Complex, SLEEP VitaCig® Edition, Kama Sutra (SEX), STRESS VitaCig® Edition, with 100% real Cocoa, Getting into the Holiday spirit early, VitaCig has just released its VitaCig Candy Cane — Holiday Limited Edition, the perfect gift or stocking stuffer for this Holiday season. Orders can be placed by visiting: http://www.vitacig.org/

VitaCBD Brand
At the CHAMPS Tradeshow in Denver, Sept. 26-28, 2016 the Company launched its new and improved VitaCBD™ Product Line to Buyer’s in the Smoke Shop Industry.

The new line consists of healthy, uniquely blended 250mg, 500mg and 1000mg tinctures… 150mg and 300mg PG Free E-Liquid… 100mg, 500mg and 1000mg Blood Orange Essential Oil Infused Topical Lotion, a complete line of relaxing melatonin and 25mg CBD Edibles, with more in the works.

The CBD Division has begun supplying Raw Hemp-Extracts to other CBD Manufacturing Companies as Cherry Hemp Oil Bulk CBD Supply Co. During its initial two week period of operations the CBD Division logged over $50,000 in sales.

With numerous Distribution Networks with their eye on VitaCBD™, a new Bulk CBD Supply Co., a heavy on-line presence, along with plans for unique, Hemp-Extract Based consumer product development phases, future growth for this new CBD Division should become a significant boost for mCig, Inc. as a whole. Orders can be placed by visiting: http://www.vitacbd.com

Rollies Division -
MCIG’s Rollies division recently entered into a partnership agreement with Nevada based company Vellum LLC. Both companies will work together on bringing to the market a new format of smoking papers and cannabis pre-roll filling services to a different marijuana businesses.

Vellum LLC provides pre-roll filling services for two California brand’s: Nativ and “Lucy’s” using a new JOINT format from MCIG. Collaboration of two companies, already generated more than 1 mil pre-rolled sold.

“MCIG’s Rollies division is finally on a roll”, says Alex Levitsky the CEO of Rollies. During the past 5 months we have been researching and testing Nevada’s marijuana market. We have met with many owners and managers of cannabis cultivation, production and dispensaries businesses. They all were highly impressed with our unique format of pre-rolls. Success of “Nativ” and “Lucy’s” have spiked tremendous interest from Las Vegas cannabis businesses. We’re in the middle of making a deal with a big cultivator/producer in Las Vegas which will significantly increase our sales volume on papers as well as filling services performed. Now, with joining forces of an experienced management team form Vellum, we would be able to expand our services rapidly to all marijuana legal states across an America.

mCig Internet
The company oversees all retail sales of mCig’s products. In May 2016, MCIG developed and approved a multifaceted operational plan for the expansion of its retail sales. The strategy has resulted in significant growth and is based upon these principles:

1. Expand domain name and website presence to capture and use to the Company’s advantage the recent and consistent changes in the Google ranking process, seeking guidance and direction from the industry experts and market leaders.

2. Develop and implement internally and externally, a system in which sales to customers can be expedited with secure privacy, yet inherent transparency.

3. Expand product sales to include not just our own proprietary products, but to be the industry leader in CBD sales.

Based upon this research, the Company acquired three specific domain names to use in conjunction with the four domain names it operates. As part of these acquisitions we have some of the best site development, SEO, and analyst in the market available to us who have provided in depth and thorough analysis of all out sites.

With the goal to propel mCig Internet towards domination of the specific industry keywords organically, and not by the conventional paid advertising methods that often prove highly ineffective, mCig Internet strives to control the primary keyword positions, and once achieve, to maintain them, at no additional costs unlike our various competitors.

Additional Updates
Omni Health, Inc. — While not recorded on the financial statements of MCIG, the Company maintains approximately a 9% interest in the company. Omni Health is the manufacturer and distributor of anti-aging creams and operates a Pharmacy operation in the Miami, Florida area.

Omni Health is conservatively projecting $6M in revenue with an 8% net profit margin for FY 2017. Omni will be more active independently promoting their company as soon as the symbol change is approved, any day now. Realizing value for our shareholders is a must and we have great plans for our position in Omni for our shareholders.


All in all, as previously stated, we feel we have created an environment where our company is a bright spot for the ancillary cannabis and hemp markets. MCIG has clearly reached an important inflection point of controlled expenses, rising revenues, and profitability. While the road was long we chose it not because it was easy, but because it was difficult and shareholder friendly. MCIG’s fiscal prudence and the avoidance of toxic debt is what has allowed us to be a diversified investment rather than a fly by night company trying to get it right at the cost of its shareholders. We are poised to flourish, rather than to fade and our corporate philosophy will continue to remain intact for the benefit of our shareholders. The recent retirement of 50,000,000 shares of stock is further testament to this fact and we will be announcing more changes to benefit shareholders as well as update shareholders to the potential impact of the November 8th ballot initiative impact, which we feel one way or another is either good news or great news for MCIG Inc. Thank you for your time.

Paul Rosenberg

About mCig, Inc.
Headquartered in Henderson, Nevada, mCig Inc. ( OTCQB : MCIG ) A diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands. MCIG has transitioned from a vaporizer manufacturer to industry leading large scale, full service cannabis cultivation construction company with its Scalable Solutions division currently operating in the rapidly expanding Nevada market. The company looks forward to growing its core competencies to service the Ancillary legal Cannabis, Hemp and CBD markets, with broader expansion to take place once federal laws change. For more information visit www.mcig.org.

Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company’s products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies.

    0 7367

    Has Smoked WEED!!!


    Michael Phelps, who is unarguably the greatest Olympian of all time (The #GOAT) has smoked marijuana. At the age of fifteen at the 2000 Athens Olympics, Phelps became the youngest male to make an Olympic swim team in almost seven decades. While he did not win at that time, he did place in the finals. During the world championship the next year, however, Phelps, still fifteen, became the youngest male ever to set a swimming world record. He then proceeded to break that record again and become the world champion.

    He continued to win world championships up until the 2004 Olympic Games, but it did not stop there. Phelps went on to break two world records during this period and won a grand total of six gold medals. The next Olympic Games Phelps was even more successful, setting seven new world records and winning a total of eight gold medals, beating Mark Spitz record of seven gold medals won in a single Olympic games.

    The following year the world was shocked to hear Michael Phelps, Wheaties cover boy did something no 20-year-old Olympian should ever do. Phelps made headlines when a picture of him surfaced with him taking a Bong Rip. To be fair, it wasn’t even a big bong and a guy like him can definitely clear a much bigger chamber with his superior lung capacity. Even so, he was under fire by moms & dads that felt this kid smoked weed. The Kellogg Company refused to be his sponsor and USA Swimming gave him a three-month suspension swimming ban. Phelps publicly apologize and was forced to admit to “inappropriate.” Should Phelps have apologized for being a kid that couldn’t legally buy beer just because a few companies said he disappointed children that held him up as a role model? Hell NO!

    If you’ve followed the news the last two days, the DEA just announced that they are unwillingly to reschedule marijuana and keep it as a class 1 drug. As a class one drug, according to the DEA Marijuana is more dangerous & addictive than Cocaine, Oxycontin and amphetamines. Yet here we have Phelps the greatest Olympic athlete of all time still winning gold at the Rio Olympics and probably still smoking weed in the off season. Phelps is proof of just how innocuous marijuana can be. Those against marijuana prohibition will state that the drug will ruin your life, make you lazy, etc. Michael Phelps destroys that argument by being the most decorated Olympian of all time with twenty-one (and counting) gold medals!

    It actually turns out that the masterminds behind the Olympics were under the same impression; in 2013, the World Anti-Doping Agency (WADA) changed their rules concerning marijuana. No one was really paying attention when they made this rule change because they were focusing on the banned substances being added. In 2016 the limit of THC in your system was moved to 150 ng/ml. Basically that means you can’t show up stoned when competing, drunk or hungover. Theoretically you can smoke a month before you compete and be a-ok.

    Congratulations Michael Phelps on being the most decorated athlete in Olympic history and being a poster boy for advocates and activists fighting to change the perception of how cannabis effects the user. You are not lazy, crazy and suffering from “Reefer Madness” as many people would try and make you believe. Keep dominating in the pool and go USA!

    5 20911

    WASHINGTON — The administration of “Yes We Can” is now the administration of “No We Won’t,” in a ruling that keep marijuana as a schedule 1 drug. No one at Marijuana Stocks is surprised by this ruling from the administration via the lengthy statement from the Drug Enforcement Administration (DEA). Again the Cannabis advocates, activists & patients in need of the properties associated with Medical Marijuana were given some crumbs in true “Hunger Games” Style. As of today’s ruling by the DEA the study of cannabis will be expanded in order to ascertain the potential medical benefits of cannabinoids. Marijuana will continue to be on the list of the most dangerous drugs, regardless of growing support for legalization and more states changing their laws to have some form of medical marijuana or recreational marijuana on the books.

    “By punting the reclassification of marijuana debate the DEA exposes themselves to the utter hypocrisy of our classification system. Consider Cocaine and OxyContin are class 2 drugs and are far more ruinous to the people that use and abuse them, yet cannabis which can’t kill you is a class 1 drug which by definition means there are no medical benefits and highly addictive.” Said an agency source under the condition of anonymity.
    The Health and Human Services Department was so bold today as to double down on the illogical argument on marijuana by saying cannabis “has a high potential for abuse” and “no accepted medical use.”
    A statement of that nature exposes some problems with that argument as well as showing who is potentially to blame for the bureaucracy surrounding these kind of government rulings. Let’s examine this statement and try and draw some conclusions on our own.

    First, if marijuana has no medical properties or potential benefits why are BigPharma companies spending hundreds of millions of dollars in research and development to study marijuana and create drugs for patients? Abbvie Inc (ABBV) has had a cannabis related drug it has marketed since 1985 for example called Marinol (Dronabinol Extract) which is an appetite stimulant used by cancer patients. INSYS Therapeutics Inc (INSY) was just given FDA approval for its orally administered drug called Syndros last month which is similar to ABBV’s appetite drug. GW Pharmaceuticals (GWPH) has a drug called Epidiolex for people suffering from seizures, they are also creating their own strains of cannabis for individual targeted Cannabinoids. Any person that has ever used medical marijuana for example knows that one of its side effects is hunger or the “munchies.” Why try and synthesize a drug when nature and thousands of years of use has produced the same result you ask? Money from prescription drugs, money from speculation on the public company creating these drugs and ridiculous ways to capitalize from the insurance that pays for it all. The reality is that cannabis is essentially a weed that grows all over the world and the pharmaceutical industry would lose potentially hundreds of billions of dollars if cannabis was federally legal. Which leads me to point two in exposing the bureaucracy tied to Big Pharma.

    So how do the lawmakers in the United States and agencies like the DEA come to these irrational conclusions that lack all common sense? Lobbyists on K Street in DC for starters. Given medical marijuana’s position as a cheaper, safer alternative to pharmaceutical products, pharmaceutical companies stand to lose a significant chunk of market share if marijuana legalization were to pass. BigPhRMA is universally recognized as marijuana’s biggest financial competitor, with drug manufacturers giving a whopping $21.8 million to a myriad of federal candidates and committees, as well as political parties during election times. In 2013 alone, Big Pharma spent approximately $18 million solely on lobbying, according to OpenSecrets. While easily one of the biggest contenders to the marijuana industry, Big Pharma was hit with a crucial turning point, a survey of 473 adult therapeutic cannabis users, conducted by the Centre for Addictions Research of BC, found that 87% of respondents gave up prescription medications, alcohol, or other drugs in favor of cannabis.

    Other Lobbies that are fighting relentlessly against cannabis are private prison corporations as well as the alcohol & tobacco industry. For mor info on that here’s an article on the top five lobby’s.

    In the end officials need to get elected and no one wants to piss off their donors, grassroots organizations like Norml or the Marijuana Policy Project are fighting a war against opponents that have unlimited resources. Even so the expansion of study does crack the door open for the industry and in our opinion prohibition will eventually end. Once the government and big business set up the infrastructure to capitalize on cannabis they will demand their piece of the pie, which has an estimated black market value of $50,000,000,000 and a legal US market estimated at $6,000,000,000. That might be a scary thought, but there will always be artisanal cannabis for the masses and the best growers in the industry don’t need to become sellouts which is positive to us.
    Here is the statement from the DEA today. Share this article, Tweet it, Facebook it, email it to your friends and congressman. Everyone must do their part or the elected officials we put in office will continue to vote against our collective interests.




    0 1443

    The United States Senate Appropriations Committee approved legislation which prevents the federal government from blocking state laws pertaining to legal medical marijuana. Last week, the House of Representatives approved similar legislation, but rejected an amendment to prevent the Justice Department from interfering with states that have legal recreational marijuana programs.

    The Senate’s amendment prohibits the Justice Department, including the Drug Enforcement Administration (DEA), from using funds to interfere in the implementation of state laws that allow the cultivation, distribution, and use of marijuana for medical purposes.

    Pro-marijuana legislation becoming a common them in D.C.

    This is the second time in as many months that the Senate Appropriations Committee has approved a marijuana policy reform measure.

    In May, the Senate Appropriations Committee approved the Veterans Equal Access Amendment, which will allow Veterans Administration (VA) doctors to recommend medical marijuana to their patients in states where it is legal. The amendment had significant bipartisan support and was sponsored by Republican Senator Steve Daines (Montana) and Democratic Senator Jeff Merkley (Oregon).

    Currently, 27 states and the District of Columbia have legalized medical marijuana, decriminalized marijuana, or both. Also, 4 states have legalized recreational marijuana and 14 states have legalized a limited form of marijuana by allowing patients access to cannabidiol (CBD).

    Positive guidance has been issued by both the Treasury and Justice Department

    In August 2013, the Justice Department issued guidance to governors of states where medical or recreational marijuana is legal. The Justice Department said it will not challenge the state’s marijuana laws if the state has a tightly regulated marijuana program.

    In February 2014, the Treasury Department issued guidance to banks and financial institutions on how to work with marijuana businesses. Although the department stated that financial institutions can offer services to businesses that dispense marijuana, most banks are reluctant to do so because of the fear of prosecution.


    In March, three Senators introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act which is a bipartisan bill that would effectively end the federal ban on medical marijuana and implement a series of reforms.

    The CARERS Act was introduced by Rand Paul, Cory Booker, and Kirsten Gillibrand and it has received increased support from other Senators such as Barbara Boxer since its submission. We hope the Senate approves the legislation passed yesterday by the House of Representatives and helps move the cannabis industry forward.

    Authored By: Michael Berger
    Michael Berger is a financial writer for MarijuanaStocks.com and the president & founder of Technical420, an independent research firm focused specifically on the cannabis sector. He was working for the equity research department at Raymond James Financial Inc., when he recognized a need for a service that provides up-to-date research and analysis on companies that operate in the cannabis industry. Mr. Berger studied finance and economics at Florida State University and is working toward achieving his CFA charter.

    0 1859

    The growth of the cannabis industry has started to gather the attention and capital of many well-known celebrities. Some of the celebrities who entered the cannabis industry were expected to enter the industry, but some of them were unlikely candidates.

    Melissa Etheridge

    Melissa Etheridge became a spokesperson for marijuana legalization after she was diagnosed with breast cancer in 2004. Etheridge said marijuana saved her life. Now, Etheridge entered the cannabis industry and she helped create a marijuana-infused wine.

    Etheridge said, “It helped with the psychological effects of being on chemo and trying to understand what’s happening to you.”

    Even though the National Institute on Drug Abuse says that mixing alcohol and cannabis can increase the negative effects of each drug, Etheridge said the cannabis in her wine is not dangerous in moderation. The cannabis used in her wine is cold pressed, never heated, and it does not have a psychoactive effect.

    “It doesn’t make you high as you and I would know it, like, ‘Whoa!'” she said. “If you’re looking to get high I would say, ‘No this this cannabis wine is not for you.'”

    Willie Nelson

    Willie Nelson recently revealed plans to launch a branded chain of marijuana dispensaries and related products, including signature strains of pot. He wants to develop and sell his own strains through his own dispensaries. Nelson plans to open his first dispensary in 2016.

    The brand will be known as “Willie’s Reserve,” and his spokesman, Michael Bowman, said the operation will be reflective of Willie’s passion for cannabis. Bowman added that he plans to market Willie’s Reserve under an “anti-Walmart model.”

    Willie Nelson is very active supporter of legalized cannabis, and he co-chairs the advisory board of the National Organization for the Reform of Marijuana Laws (NORML). Willie Nelson has been arrested quite a few times for possessing marijuana, the last time being in 2010. During that arrest, police in Texas seized 6 ounces of cannabis from his tour bus.

    Snoop Dogg

    Snoop Dogg recently entered the cannabis industry through a partnership with Grenco Science Vaporizer Company. The company will develop a line of vaporizer pens and accessories for Snoop under his own brand called, Double G Series.

    In February, Snoop announced that he is working on creating an investment fund that will invest in cannabis startup companies. The fund is trying to raise $25 million to fund investments focused on technology related companies in the marijuana industry.

    Snoop Dogg is considered to be a weed connoisseur and he is following Peter Lynch’s advice by “investing in what you know.” Snoop’s investment brings more than just capital to the industry. Snoop is a well-known celebrity who is well connected in Hollywood. Technical420 expects to see his notoriety and connections generate investment interest among other celebrities.

    Bob Marley

    Privateer Holdings, a Seattle based private equity firm focused on marijuana investments, launched Marley Natural, the first global marijuana brand based on Bob Marley. His family has endorsed the brand, and Privateer says that it will use Jamaican strains to sell Marley Natural marijuana around the world.

    Marley Natural is the first brand in Privateer’s growing club of cannabis companies to focus on the sale of accessories, cannabis-infused products, and marijuana. Marley Natural plans on having its products available in the latter half of 2015.

    Privateer Holdings hired Heckler & Associates, the marketing group that branded New Balance and Starbucks to direct brand development. Brendan Kennedy, Privateer Holdings’ CEO, said that the acquisition of Marley Natural builds instant brand recognition that would have otherwise taken 5 to 10 years.

    Bethenny Frankel

    Bethenny Frankel of The Real Housewives of New York City and owner of the Skinny Girl empire is planning on launching a Skinnygirl marijuana brand.

    Frankel wants to introduce a variety of marijuana that is engineered “to not give you the munchies.” We are interested in seeing how this product sells (when/if it launches) within the marijuana community.

    Authored By: Michael Berger
    Michael Berger is a financial writer for MarijuanaStocks.com and the president & founder of Technical420, an independent research firm focused specifically on the cannabis sector. He was working for the equity research department at Raymond James Financial Inc., when he recognized a need for a service that provides up-to-date research and analysis on companies that operate in the cannabis industry. Mr. Berger studied finance and economics at Florida State University and is working toward achieving his CFA charter.


    0 1841

    The first seven months of 2015 have been record breaking for Colorado. The state has already generated almost as much tax revenue from marijuana when compared to 2014. Colorado is on pace to double its numbers from last year and generate $125 million in tax revenue during 2015. Our analysts expect this number to continue to move higher year-over-year and we think this just the start of something big.

    In 2014, Colorado brought in $76 million in tax revenue from marijuana. The state has already collected $73.5 million in taxes during 2015. Of the $73.5 million, $19.6 million has been set aside to fund Colorado’s public schools. This growth is outstanding when you compare it to 2014. During 2014, Colorado’s public schools received $13.3 million from the marijuana taxes collected.

    Colorado Makes History

    The Colorado marijuana industry is proving to be a more profitable business for the state than alcohol. During the 2014 fiscal year, Colorado generated $70 million from marijuana. During the same period, the state collected less than $42 million from alcohol taxes.

    This development is historic because Colorado is the first state to generate more revenue from marijuana than alcohol.

    A Ground Floor Opportunity

    There are a number of investment opportunities in the Colorado cannabis industry and investors need to conduct thorough due diligence before investing. This industry is just getting started and continues to see growth even though it is constrained.

    In early 2015, our analysts developed a model which projects cannabis to be a $500 billion industry by 2030. This growth will be primarily due to the medical applications, a booming hemp industry, ancillary businesses and from the sale of marijuana.

    Authored By: Michael Berger
    Michael Berger is the president and founder of Technical420, an independent research firm focused specifically on the cannabis sector. He was working for the equity research department at Raymond James Financial Inc., when he recognized a need for a service that provides up-to-date research and analysis on companies that operate in the cannabis industry. Mr. Berger studied finance and economics at Florida State University and is working toward achieving his CFA charter.


    Michael Berger


    Technical 420 LLC

    C: 305-458-9982

    E: michael.berger@technical420.com

    W:  www.technical420.com


    0 1558

    The Seneca Nation joined the growing list of tribes who have expressed interest in the legal marijuana industry. Seneca Nation President Maurice John, Sr., recently discussed his views on the industry and said the tribe has been monitoring it closely from the sidelines.

    A Waiting Game

    In December 2014, the United States Department of Justice said Native American tribes can grow and sell marijuana on sovereign lands. The tribes must follow the federal guidelines in the four states where it is legal for recreational use.

    The United States is home to 326 federally recognized reservations and 566 federally recognized tribes, most of which are located in states that ban the use of marijuana for recreational purposes. Many tribes are in the process of evaluating the DOJ’s decision and will be discussing it with their respective councils.

    First tribe enters legal marijuana industry

    In mid-June, the Flandreau Santee Sioux Tribe became the first reservation in South Dakota to legalize marijuana. The tribe was also the first Native America tribe to legalize marijuana in a state where the use and sale of marijuana is illegal.

    The tribe hired Monarch America Inc. (BTFL) to design, construct and develop a grow facility on the Flandreau reservation and the company expects it be open by the first week of December.

    South Dakota Attorney General Marty Jackley is not happy with these recent developments and he called the Justice Department’s Cole Memorandum “a complex directive that has created confusion on the tribal front.”

    The Cole Memorandum outlined acceptable conditions under which Native American tribes could produce and sell marijuana.

    Tribe is changing the South Dakota legal landscape

    Although Attorney General Jackley is not pleased with the announcement, he recently proposed a bill that would decriminalize the possession of up to one ounce of marijuana in South Dakota. The state can soon start collecting signatures to place the issue on the November 2016 ballot.

    If the measure is approved by voters, the possession of up to one ounce of marijuana would no longer be a crime.  Adults 18 and older would be subject to a $100 fine and must forfeit their marijuana. The fine would double if it is not paid within 90 days.

    Currently, the possession of up to two ounces of marijuana is a Class 1 misdemeanor in South Dakota, punishable by fines up to $2,000 and a year in prison.  The proposed initiative would not change penalties for the possession of more than one ounce, however, the possession of more than one ounce but less than two ounces would remain a misdemeanor (more than two ounces would remain a felony).

    Under South Dakota law, the Attorney General is responsible for preparing explanations for proposed initiated measures, referred laws, and South Dakota Constitutional Amendments. Specifically, the explanation includes a title, an objective, clear and simple summary of the purpose and effect of the proposed measure and a description of the legal consequences. You can view Attorney General Jackle’s explanation here.


    When states consider legalizing marijuana for medical or recreational use the answer is not always clear. If the federal government provided any insight on the matter or had a list of guidelines to follow, the decision might be an easier one to make. For this reason, it makes sense that many tribes did not hop on board following the DOJ’s decision.

    The outcome of the Flandreau Tribe’s marijuana plans will serve as a catalyst for other tribes if it proves to be successful.  The success of this project may also serve as a catalyst to Monarch America (BTFL) because the company will see increased demand for its services from other tribes.


    Important Investor Disclosures:

    Technical 420 LLC, and any of its directors, officers, employees, affiliates, or subsidiaries does not accept any form of compensation from companies in return for writing reports on them. Also Technical 420 LLC, and any of its directors, officers, employees, affiliates, or subsidiaries do not hold any stock positions in companies covered by Technical420LLC

    Authored By: Michael Berger

    Michael Berger is the president and founder of Technical420, an independent research firm focused specifically on the cannabis sector. He was working for the equity research department at Raymond James Financial Inc., when he recognized a need for a service that provides up-to-date research and analysis on companies that operate in the cannabis industry. Mr. Berger studied finance and economics at Florida State University and is working toward achieving his CFA charter.


    Michael Berger


    Technical 420 LLC

    C: 305-458-9982

    E: michael.berger@technical420.com

    W:  www.technical420.com


    0 1803

    Painkillers have become a serious issue in the United States. During the past 15 years, America has seen a tremendous growth in both the sales of prescription opiates and the number of people who die each year from abusing them. According to the Center for Disease Control (CDC), painkillers accounted for 60% of all overdose deaths in 2013. Researchers from the RAND Corporation and the University of California-Irvine (UCI) may have found the answer and that is marijuana.

    The researchers discovered a reduction in the number of opioids related overdoses, as well as a reduction in number admissions to addiction treatment center in states that legalized marijuana. The researchers also found that these states experienced significant reductions in both measures if they also legalized marijuana dispensaries.

    In the six states where doctors can prescribe marijuana, but retail dispensaries are prohibited, the study found no evidence of reductions in substance abuse or mortality. In the 18 states where medical marijuana dispensaries are allowed, the researchers found a 16% reduction in opioid-related mortality and 28% reduction in opioid-abuse treatment admissions.

    No one has ever died from smoking marijuana

    No one has ever died from smoking marijuana but every year more than half a million people die from alcohol and tobacco. Every year, people die from the following substances:

    • 400,000 people die from tobacco
    • 100,000 people die from alcohol
    • 20,000 people die from legal drugs
    • 15,000 people die from illegal drugs
    • 2,000 people die from caffeine
    • 500 people die from aspirin

    Joe Rogan said it best: The only reason why marijuana is illegal is because of economics. If marijuana was legal, it would cost pharmaceutical and alcohol companies billions of dollars every year.  The Partnership for a Drug-Free America is funded by alcohol companies. Alcohol is a sanctioned drug!

    Authored By: Michael Berger

    Michael Berger is the president and founder of Technical420, an independent research firm focused specifically on the cannabis sector. He was working for the equity research department at Raymond James Financial Inc., when he recognized a need for a service that provides up-to-date research and analysis on companies that operate in the cannabis industry. Mr. Berger studied finance and economics at Florida State University and is working toward achieving his CFA charter.


    Michael Berger


    Technical 420 LLC

    C: 305-458-9982

    E: michael.berger@technical420.com

    W:  www.technical420.com


    Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

    We are your #1 source for all things Marijuana Stocks, Subscribe Below!

    Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
    Ad Placements